Array of cutaneous adverse effects associated with sorafenib

被引：36
|
作者：
Kong, Heidi H. [1 ]
Turner, Maria L. [1 ]
机构：
[1] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2009年 / 61卷 / 02期
关键词：
D O I：
10.1016/j.jaad.2009.02.004
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：360 / 361
页数：2
相关论文
共 50 条
  • [1] Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor
    Autier, Julien
    Escudier, Bernard
    Wechsler, Janine
    Spatz, Alain
    Robert, Caroline
    ARCHIVES OF DERMATOLOGY, 2008, 144 (07) : 886 - 892
  • [2] Antiangiogenic Agents and the Skin: Cutaneous Adverse Effects of Sorafenib, Sunitinib, and Bevacizumab
    Ara, M.
    Pastushenko, E.
    ACTAS DERMO-SIFILIOGRAFICAS, 2014, 105 (10): : 900 - 912
  • [3] Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib
    Lee, W. J.
    Lee, J. L.
    Chang, S. E.
    Lee, M. W.
    Kang, Y. K.
    Choi, J. H.
    Moon, K. C.
    Koh, J. K.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (05) : 1045 - 1051
  • [4] Sorafenib: atypical cutaneous side effects
    Richetta, Antonio Giovanni
    Maiani, Elisa
    Carboni, Valentina
    Carlomagno, Valentina
    Cimillo, Manuella
    Mattozzi, Carlo
    Calvieri, Stefano
    EUROPEAN JOURNAL OF DERMATOLOGY, 2007, 17 (06) : 549 - 550
  • [5] Cutaneous side effects of sorafenib and sunitinib
    Autier, J.
    Mateus, C.
    Wechsler, J.
    Spatz, A.
    Robert, C.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2008, 135 (02): : 148 - 153
  • [6] Spiny Follicular Hyperkeratosis Eruption: A New Cutaneous Adverse Effect of Sorafenib
    Franck, Nathalie
    Barete, Stephane
    Moguelet, Philippe
    Blanchet, Benoit
    Carlotti, Agnes
    Ropert, Stanislas
    Avril, Marie Francoise
    Frances, Camille
    Billemont, Bertrand
    Goldwasser, Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (31) : E640 - E642
  • [7] Temporary suspension of sorafenib by adverse effects is associated with longer survival in patients with hepatocellular carcinoma
    Rodriguez-Escaja, C.
    Turrion, M. A. de Jorge
    Garcia, A. C.
    Diaz, E. R.
    Gonzalez-Dieguez, M. L.
    Alvarez-Navascues, C.
    Cadahia-Rodrigo, V.
    Rodriguez, M.
    Varela, M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S448 - S448
  • [8] The Adverse Effects of Sorafenib in Patients with Advanced Cancers
    Li, Ye
    Gao, Zu-Hua
    Qu, Xian-Jun
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 116 (03) : 216 - 221
  • [9] Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib
    Zuo, Rena C.
    Apolo, Andrea B.
    DiGiovanna, John J.
    Parnes, Howard L.
    Keen, Corrine M.
    Nanda, Swati
    Dahut, William L.
    Cowen, Edward W.
    JAMA DERMATOLOGY, 2015, 151 (02) : 170 - 177
  • [10] Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
    Lacroix, Jean-Philip
    Wang, Beatrice
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2017, 21 (01) : 54 - 59
12345